Talis Biomedical Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TLIS research report →
About the company
Talis Biomedical Corporation specializes in molecular diagnostics, focusing on the creation of its Talis One system. This system is being developed to address and resolve existing limitations within current point-of-care diagnostic testing technologies for infectious diseases. The company currently provides the Talis One COVID-19 Test System, which is specifically designed for the detection of SARS-CoV-2, the virus responsible for COVID-19.
- CEO
- Rebecca Markovich
- IPO
- 2021
- Employees
- 99
- HQ
- Menlo Park, CA, US
Price Chart
- Market Cap
- $5.18M
- P/E
- -0.08
- P/S
- 12.57
- P/B
- 0.07
- EV/EBITDA
- 0.79
- Div Yield
- 0.00%
- Gross Margin
- 90.05%
- Op Margin
- -16217.23%
- Net Margin
- -15050.24%
- ROE
- -63.32%
- ROIC
- -70.09%
- Revenue
- $412.00K · -88.72%
- Net Income
- $-62,007,000 · 45.13%
- EPS
- $-34.12 · 46.39%
- Op Income
- $-66,815,000
- FCF YoY
- 47.20%
- 52W High
- $2.84
- 52W Low
- $1.04
- 50D MA
- $2.37
- 200D MA
- $1.72
- Beta
- 1.32
- Avg Volume
- 1.18K
Get TickerSpark's AI analysis on TLIS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 6, 24 | Leonard Braden Michael | buy | 25,000 |
| Sep 5, 24 | Leonard Braden Michael | buy | 5,100 |
| Sep 3, 24 | Leonard Braden Michael | buy | 500 |
| Aug 30, 24 | Leonard Braden Michael | buy | 151 |
| Aug 28, 24 | Leonard Braden Michael | buy | 1,215 |
| Aug 26, 24 | Leonard Braden Michael | buy | 13,167 |
| Aug 14, 24 | Leonard Braden Michael | other | 0 |
| Jul 31, 24 | Ferrari Patricia | other | 0 |
| Jul 31, 24 | Young John T. Jr. | other | 0 |
| Aug 1, 23 | Lukowiak Andrew A | other | 30,575 |
Our TLIS coverage
Recent articles, reports, and earnings notes.
No research on TLIS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TLIS report →Similar companies
Peers in the same neighborhood.